Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page
- Check9 days agoChange DetectedThe page's related topics metadata was updated to include 'Ovarian cancer' and 'MedlinePlus Genetics'. This change broadens how the study is indexed for ovarian cancer-related searches without altering the study content.SummaryDifference0.1%

- Check17 days agoChange DetectedA revision/version label on the page was updated from the prior release, indicating a minor ClinicalTrials.gov site change. Additionally, some “related topics” entries in the auxiliary information area (e.g., MedlinePlus Genetics) were removed, without affecting the study details.SummaryDifference0.2%

- Check24 days agoChange Detected- Updated bibliographic reference: revision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded the Ovarian cancer topic and a MedlinePlus Genetics related topic, and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.2%

- Check73 days agoChange DetectedOvarian cancer and the MedlinePlus Genetics related topic were removed from the page's related topics.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.